These findings provide new and important information on the progression of HCC and suggest that IFITM3, particularly rs12252-CC genotype, may be beneficial as a novel molecular target for the treatment and diagnosis of HCC patients. The gene discussed is IFITM3; the disease is hepatocellular carcinoma.